PhosBERT: A self-supervised learning model for identifying phosphorylation sites in SARS-CoV-2-infected human cells

Yong Li1, Ru Gao2, Shan Liu3

  • 1Sichuan Vocational College of Health and Rehabilitation, Zigong 643000, Sichuan, China.

PubMed

Insights

A new computational model, PhosBERT, accurately identifies SARS-CoV-2-infected phosphorylation sites in host cells. This tool aids understanding of COVID-19 mechanisms and antiviral drug discovery.

Area of Science:

  • Computational Biology
  • Virology
  • Biochemistry

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, leading to protein post-translational modification dysregulation in host cells.
  • Understanding these modifications, particularly phosphorylation sites, is crucial for elucidating SARS-CoV-2 pathogenesis and identifying antiviral therapies.

Purpose of the Study:

  • To develop a cost-effective and high-precision computational strategy for identifying SARS-CoV-2-infected phosphorylation sites.
  • To enhance the understanding of viral-host interactions at the molecular level.

Main Methods:

  • Implementation of a custom neural network model, PhosBERT, based on the pre-trained protein language model ProtBert.
  • Training and validation using serine (S), threonine (T), and tyrosine (Y) phosphorylation datasets with 5-fold cross-validation.

Main Results:

  • PhosBERT achieved high accuracy in identifying S/T phosphorylation sites (81.9% accuracy, 0.896 AUC).
  • PhosBERT demonstrated high prediction accuracy for Y phosphorylation sites (87.1% accuracy, 0.902 AUC).
  • The model exhibited good prediction ability and stability in independent validation.

Conclusions:

  • PhosBERT provides a novel and effective computational approach for studying SARS-CoV-2-associated phosphorylation sites.
  • This tool can significantly contribute to understanding COVID-19 mechanisms and accelerate antiviral drug screening.